Dhananjay Taumar | Pharmaceutical Sciences | Best Academic Researcher Award

Published on | Editorial Board by World Top Scientists

Best Academic Researcher Award

Dhananjay Taumar –  IIMT University Meerut

 Dhananjay Taumar
Affiliation IIMT University Meerut
Country India
Scopus ID 58785853500
Documents 14
Citations 16
h-index 1
Subject Area Pharmaceutical Sciences
Event Name World Top Scientist Awards
ORCID 0009-0008-8967-4672

This article presents an academic overview of the research profile of Dhananjay Taumar, affiliated with IIMT University Meerut, in relation to the Best Academic Researcher Award. The summary follows a neutral encyclopedic style and highlights publicly available scholarly indicators including publication output, citations, research interests, and persistent researcher identifiers. The information is intended for academic reference and reflects recognized research indexing practices.[1]

Abstract

Dhananjay Taumar’s documented research activity is indexed through internationally recognized scholarly databases and reflects contributions within pharmaceutical sciences. Available metrics indicate fourteen indexed documents together with citation activity and an h-index that collectively provide measurable evidence of research dissemination. Such indicators are commonly used for institutional evaluation, research visibility, and academic recognition while being interpreted alongside qualitative scholarly assessment.[2]

Keywords

Pharmaceutical Sciences, Scopus, ORCID, Academic Research, Citation Analysis, Scholarly Publishing, Research Metrics, Research Evaluation.

Introduction

Academic awards frequently consider research productivity, publication quality, citation influence, and sustained scholarly engagement. International indexing platforms improve transparency by providing standardized author profiles and publication records that assist institutions and award committees in evidence-based evaluation. Persistent researcher identifiers further enhance attribution and long-term discoverability.[3]

Research Profile

The available profile indicates that Dhananjay Taumar is affiliated with IIMT University Meerut and conducts research within pharmaceutical sciences. The author’s Scopus profile and ORCID identifier contribute to reliable scholarly identification across publishers and indexing systems. These resources support research integrity, author disambiguation, and consistent academic reporting.[1]

Research Contributions

Research contributions in pharmaceutical sciences commonly include experimental studies, reviews, collaborative investigations, and scientific communication that advance understanding within the discipline. Indexed publications enable peer verification while citation records demonstrate continuing engagement by the scholarly community. These characteristics form important components of academic assessment.[4]

Publications

The publication record of Dhananjay Taumar reflects a consistent research focus on pharmaceutical sciences, nanotechnology-based drug delivery, neuropharmacology, and modern therapeutic strategies. Recent publications indexed through ORCID and Scopus include studies on silica-based nanocarriers, gene delivery, antimicrobial peptides, inflammatory disorders, and precision medicine. These scholarly works demonstrate interdisciplinary collaboration with researchers from multiple institutions while addressing contemporary healthcare challenges through evidence-based pharmaceutical research.[2]

Research Impact

The research impact of Dhananjay Taumar may be evaluated using internationally accepted scholarly indicators such as indexed publications, citation count, author profile visibility, and persistent digital identifiers. Available records indicate active publication in peer-reviewed journals together with measurable citation activity that contributes to the visibility of his scientific work. The combination of ORCID registration, Scopus indexing, and DOI-linked publications supports transparency, accessibility, and long-term discoverability of research outputs within the global academic community.[3]

Award Suitability

Recognition through academic awards generally considers research quality, publication consistency, citation performance, institutional affiliation, and scholarly contribution to the advancement of knowledge. Based on publicly available academic records, Dhananjay Taumar possesses verifiable research credentials supported by indexed publications and internationally recognized researcher identifiers. The final determination of eligibility for the World Top Scientist Awards remains subject to the official evaluation process and independent selection criteria established by the award organizing committee.[4]

Conclusion

The academic profile presented in this article summarizes publicly available information relating to Dhananjay Taumar’s scholarly activities, institutional affiliation, publication record, and research identifiers. The available evidence indicates ongoing contributions within pharmaceutical sciences through peer-reviewed publications and collaborative research initiatives. This information serves as an objective academic overview intended for reference purposes and supports transparent documentation of scholarly achievements within internationally recognized research databases.[5]

References

  1. Taumar, D., Singh, A. P., Sharma, H., Gohri, S., & Chaudhary, V. (2026). Silica based nanocarriers for combination immunotherapy targeting the tumor immune microenvironment. Drug Delivery and Translational Research. https://doi.org/10.1007/s13346-026-02131-8
  2. Taumar, D., Singh, A. P., Sharma, H., Shamim, Gohri, S., & Chaudhary, V. (2026). Mechanistic and safety evaluation of standardized traditional Chinese medicine formulations and their bioactive constituents in ICD-11-classified inflammatory skin diseases: A structured narrative review. https://doi.org/10.1016/j.prmcm.2026.100827
  3. Taumar, D., Kumar, A., Singh, A. P., & Dhama, N. (2026).
    ROS-responsive baicalin hydrogel from Scutellaria baicalensis for targeted modulation of cutaneous inflammation: Mechanistic insights and translational perspectives. https://doi.org/10.1016/j.prmcm.2026.100807
  4. Shamim, Singh, A. P., Sharma, H., Gohri, S., Taumar, D., & Chaudhary, V. (2026). Exosome mimetic nanoparticles for siRNA based targeting of α-synuclein and neuroinflammation in Parkinson’s disease. https://doi.org/10.1093/jpp/rgag052
  5. Kumar, S., Taumar, D., Gaikwad, S., More, A., Nema, V., & Mukherjee, A. (2024).
    Antiretroviral action of Rosemary oil-based atazanavir formulation and the role of self-nanoemulsifying drug delivery system in the management of HIV-1 infection. https://doi.org/10.1007/s13346-023-01492-8

Klaus Schmitz-Abe | Medicine and Dentistry | Best Researcher Award | 4538

Published on | Editorial Board by World Top Scientists

Best Researcher Award

Klaus Schmitz-Abe
Affiliation University of Miami
Country United States
Scopus ID 55566516000
Documents 2133
Citations 2284
h-index 26
Subject Area Medicine and Dentistry
Event World Top Scientist Awards
ORCID 0000-0002-7242-8861

Klaus Schmitz-Abe – University of Miami

Klaus Schmitz-Abe is a biomedical researcher affiliated with the University of Miami and recognized for his contributions to genomic medicine, rare disease research, computational biology, and clinical genetics. His academic activities integrate advanced sequencing technologies, bioinformatics methodologies, and translational research approaches that support the identification and interpretation of disease-causing genetic variants. Through collaborations with leading healthcare and research institutions, he has contributed to projects focused on improving diagnostic precision and expanding knowledge of inherited disorders. His research profile reflects a multidisciplinary approach that bridges computational science with clinical medicine, supporting innovation in precision healthcare and evidence-based patient management.[1]

Abstract

This article presents an academic overview of Klaus Schmitz-Abe in relation to the Best Researcher Award. His research activities encompass genomic medicine, human genetics, rare disease diagnostics, computational biology, and translational healthcare. Through collaborative investigations and publication of peer-reviewed studies, he has contributed to improving the understanding of genetic disorders and advancing modern diagnostic methodologies. His work demonstrates the integration of bioinformatics, sequencing technologies, and clinical interpretation frameworks that support precision medicine initiatives. The combination of scientific productivity, interdisciplinary collaboration, and translational relevance highlights a research profile suitable for international academic recognition.[2]

Keywords

Genomic Medicine, Human Genetics, Rare Diseases, Bioinformatics, Clinical Genomics, Precision Medicine, Immunology, Translational Research.

Introduction

The growing importance of genomic technologies has transformed the way researchers investigate inherited diseases and complex medical conditions. Scientists working in this field contribute significantly to improving diagnostic accuracy and expanding the understanding of disease mechanisms. Klaus Schmitz-Abe has participated in research efforts that combine computational methods with clinical investigation, creating opportunities for more efficient genetic diagnosis and personalized healthcare solutions. His scholarly work reflects the evolving role of genomics in contemporary medicine and biomedical research.[3]

Research Profile

Klaus Schmitz-Abe has held research and academic appointments associated with the University of Miami, Harvard Medical School, Boston Children’s Hospital, and several collaborative genomic research initiatives. His expertise includes next-generation sequencing, variant interpretation, copy number variation analysis, phenotype-driven diagnostics, and bioinformatics. These areas of specialization have enabled him to participate in multidisciplinary projects involving rare diseases, immune disorders, and developmental conditions. His professional activities demonstrate continuous engagement with clinical and translational research programs focused on improving patient outcomes through genomic science.[1]

Research Contributions

The scientific contributions of Klaus Schmitz-Abe include studies addressing genetic disorders, immunological diseases, autism spectrum conditions, and genomic diagnostic methodologies. His work frequently focuses on identifying clinically relevant genetic variants and improving analytical frameworks used in medical genetics. Several publications highlight the application of computational approaches and integrated genomic analyses that increase diagnostic yield and support precision medicine. These contributions have enhanced scientific understanding while also providing practical value for clinical decision-making and healthcare innovation.[4]

Publications

  • Unique Signatures of Highly Constrained Genes Across Publicly Available Genomic Databases (2025).
  • RELMβ Sets the Threshold for Microbiome-Dependent Oral Tolerance (2025).
  • DOCK8 Deficiency Due to a Deep Intronic Variant in Hyper-IgE Syndrome (2024).
  • Homozygous Deletions Implicate Non-Coding Epigenetic Marks in Autism Spectrum Disorder (2020).
  • Unique Bioinformatic Approach and Comprehensive Reanalysis Improve Diagnostic Yield of Clinical Exomes (2019).

These publications illustrate sustained engagement with genomics, immunology, and rare disease research. The studies collectively demonstrate an emphasis on clinically relevant discoveries, methodological innovation, and translational applications. Research findings reported in these works contribute to the advancement of genetic diagnostics and support broader scientific efforts aimed at understanding disease biology and improving patient care.[5]

Research Impact

Research impact can be assessed through scholarly productivity, citation influence, collaborative participation, and translational significance. The academic record associated with Klaus Schmitz-Abe demonstrates continued involvement in projects that address important challenges in genomic medicine and clinical genetics. His contributions have supported the development of diagnostic strategies and generated findings relevant to healthcare professionals, researchers, and patients. The combination of scientific output and practical relevance strengthens the overall significance of his research portfolio.[2]

Award Suitability

The Best Researcher Award recognizes excellence in scientific achievement, innovation, collaboration, and measurable academic contribution. Klaus Schmitz-Abe’s work aligns with these criteria through his multidisciplinary research activities and sustained publication record. His involvement in genomic medicine, rare disease investigation, and computational biology reflects a commitment to advancing scientific knowledge while supporting practical clinical applications. Such achievements provide a strong foundation for recognition within an international academic award framework.[3]

Conclusion

Klaus Schmitz-Abe has developed a research profile characterized by interdisciplinary collaboration, scientific productivity, and contributions to genomic medicine. His work supports advances in rare disease diagnosis, precision medicine, and computational genetics while maintaining strong relevance to modern healthcare challenges. Through peer-reviewed publications, collaborative research programs, and translational investigations, he has contributed to the ongoing evolution of biomedical science. These accomplishments collectively support his recognition within the Best Researcher Award category.[4]

References

  1. ORCID. Klaus E. Schmitz-Abe Profile.
    https://orcid.org/0000-0002-7242-8861
  2. Unique Signatures of Highly Constrained Genes Across Publicly Available Genomic Databases.
    https://doi.org/10.1016/j.gim.2025.101413
  3. RELMβ Sets the Threshold for Microbiome-Dependent Oral Tolerance.
    https://doi.org/10.1038/s41586-024-08440-7
  4. DOCK8 Deficiency Due to a Deep Intronic Variant in Two Kindreds with Hyper-IgE Syndrome.
    https://doi.org/10.1016/j.clim.2024.110384
  5. Unique Bioinformatic Approach and Comprehensive Reanalysis Improve Diagnostic Yield of Clinical Exomes.
    https://doi.org/10.1038/s41431-019-0401-x

Sara Franzi | Biology Transplantology | Women Researcher Award

Published on | Editorial Board by World Top Scientists

Dr. Sara Franzi | Biology Transplantology | Women Researcher Award

Researcher | Policlinico of Milan | Italy

Dr. Sara Franzi is a Researcher at the IRCCS Ca’ Granda Ospedale Maggiore Policlinico in Milan, specializing in transplantation biology and biomedical research. She holds advanced academic training in life sciences, with a strong foundation in molecular and cellular biology. Her professional trajectory includes postdoctoral fellowships and research appointments at leading Italian IRCCS institutes, where she has contributed to multidisciplinary projects in thoracic surgery, lung transplantation, neuroimmunology, and neuromuscular diseases. Her work spans experimental and translational research, including studies on TGF-beta signaling in myopathies, genetic determinants of drug response in myasthenia gravis, and immune-mediated neurological disorders. She has demonstrated leadership in coordinating research initiatives and contributes to scientific dissemination as a medical writer and reviewer for peer-reviewed journals. Dr. Franzi’s research output includes publications in reputable journals, reflecting her commitment to advancing knowledge in transplantation and disease mechanisms. Her professional affiliations, editorial contributions, and continued engagement in high-impact research underscore her recognition within the scientific community.

Citation Metrics (Google Scholar)

392
300
200
100
0

392

11

10

Citations

Documents

h-index


Top 5 Featured Publications

 

Rabab Hassan Elshaikh Mahmoud | Hematology | Research Excellence Award

Published on | Editorial Board by World Top Scientists

Assist. Prof. Dr. Rabab Hassan Elshaikh Mahmoud | Hematology | Research Excellence Award

Assistant professor | A’ Sharqiyah University | Oman

Assist. Prof. Dr. Rabab Hassan Elshaikh Mahmoud is an Assistant Professor in Medical Laboratory Sciences at A’Sharqiyah University, specializing in hematology, immunohematology, and immunology, with extensive expertise bridging academic research and clinical laboratory practice. She holds advanced degrees in medical laboratory science with specialization in hematology and immunology, complemented by formal training in business administration, quality management, and laboratory safety. With nearly two decades of professional experience, she has served in academic teaching, graduation project supervision, laboratory leadership, quality coordination, and program review roles, contributing to curriculum development and accreditation activities. Her research focus spans hematologic disorders, transfusion medicine, immunological diagnostics, laboratory quality systems, and clinical pathology, with published work cited internationally and active involvement as a peer reviewer for scientific journals. Her professional standing is reinforced by international certifications, licensure from multiple health authorities, participation in global accreditation programs, and membership in recognized professional societies, reflecting sustained commitment to research excellence, quality advancement, and scientific integrity in laboratory medicine.

Citation Metrics (Google Scholar)

247
200
150
100
50
0

247

6

4

Citations

h-index

i10-index


Top 5 Featured Publications

 

Jeimylo De Castro| Medicine and Dentistry | Research Excellence Award

Published on | Editorial Board by World Top Scientists

Prof. Dr. Jeimylo De Castro| Medicine and Dentistry | Research Excellence Award

Medical Director | SMARTMD | Philippines

Prof. Dr Jeimylo de Castro is a clinician-researcher with a strong scholarly focus on musculoskeletal ultrasound, regenerative medicine, chronic pain, neuropathic pain, lifestyle medicine, and non-surgical interventions, supported by peer-reviewed publications, book chapters, editorial leadership, and consistent citation impact. Author Strengths: the author demonstrates translational research expertise, leadership in emerging therapeutic technologies, interdisciplinary integration of imaging and regenerative approaches, and active engagement as a reviewer and academic contributor, reflecting credibility and influence within specialized research communities. Areas of Improvement: expanding multi-center research collaborations, increasing publication volume in high-impact journals, and strengthening longitudinal outcome studies could further enhance visibility and citation reach. Future Potential: the author shows strong promise to lead innovation-driven research, mentor future investigators, and shape global practice standards through evidence-based scholarship and international academic engagement.

 

Citation Metrics (Google Scholar)

14
10
7
4
0

14

12

2

Citations

Documents

h-index

Yi-Shan Liu | Dermatology | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Assoc. Prof. Dr. Yi-Shan Liu | Dermatology | Best Researcher Award

Chairman | I-Shou University | Taiwan

Assoc. Prof. Dr. Yi-Shan Liu, a leading dermatologist and aesthetic medicine specialist, serves as Chief of the Department of Dermatology and Minister of the Advanced Anti-Aging and Aesthetic Medicine Center at E-Da Hospital, where she is recognized for her clinical leadership and interdisciplinary expertise. She holds advanced degrees in medicine, law in business administration, and science education, reflecting a broad academic foundation that enhances her integrative approach to patient care, medical education, and translational research. Her professional experience spans progressive roles across major medical centers, where she has led dermatology services, contributed to aesthetic medicine initiatives, and guided multidisciplinary teams in delivering high-standard clinical practices. Her research focuses on dermatology, aesthetics, anti-aging science, and applied corneotherapy, with contributions that extend to scholarly publications, collaborative investigations, and international academic engagement. She has earned appointments as an associate professor across multiple academic programs and is an active member of numerous professional societies in dermatology and related fields, reflecting her recognized standing in the global medical community. Her professional certifications in medicine, dermatology, and hyperbaric and undersea medicine further attest to her clinical competence and commitment to continuous advancement. Dr. Liu’s combination of scholarly accomplishment, leadership experience, research productivity, and professional recognition positions her as an exemplary candidate for distinguished award nomination.

Profiles: ORCID

Featured Publications

1. Li, T. S., Wu, M. S., Sun, C. K., & Liu, Y. S. (2025). A novel banana method for surgical treatment of distal phalangeal glomus tumor. Asian Journal of Surgery, 48(11), 7228–7229.

2. Liu, Y. S., Lai, M. C., Hong, T. Y., & Liu, I. M. (2025). γ-Oryzanol: A nutrient-rich ingredient for promoting wound healing. Heliyon, 11(4), e42551.

3. Liu, Y.-S., Lai, M.-C., Tzeng, Y.-C., & Liu, I.-M. (2025). Polyphenolic hispolon derived from medicinal mushrooms of the Inonotus and Phellinus genera promotes wound healing in hyperglycemia-induced impairments. Nutrients, 17(2), 266.

4. Liu, Y.-S., Lai, M.-C., Hong, T.-Y., & Liu, I.-M. (2024). Exploring the wound healing potential of hispidin. Nutrients, 16(18), 3161.

5. Siregar, P., Liu, Y.-S., Casuga, F. P., Huang, C.-Y., Chen, K. H.-C., Huang, J.-C., Hung, C.-H., Lin, Y.-K., Hsiao, C.-D., & Lin, H.-Y. (2024). Optimization of laser-based method to conduct skin ablation in zebrafish and development of deep learning-based method for skin wound-size measurement. Inventions, 9(2), 25. (Co-first author)

Dr. Yi-Shan Liu’s work advances scientific understanding and clinical practice in dermatology, aesthetic medicine, and wound healing through integrative research and evidence-based innovation. Her contributions support improved patient outcomes, foster translational solutions for regenerative and anti-aging therapies, and strengthen global collaboration in emerging biomedical technologies.

Aneta Guzek | Bloodstream Infections | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Dr. Aneta Guzek | Bloodstream Infections | Best Researcher Award

Head of Microbial Laboratory | National Research Institute | Poland

Dr. Aneta Guzek is the Head of the Microbiology Laboratory at the Military Institute of Medicine – National Research Institute in Warsaw, Poland, specializing in medical microbiology and laboratory diagnostics. She holds a PhD in medicine with a specialization in medical microbiology from the Military Institute of Medicine, complemented by postgraduate qualifications in medical microbiology from the Medical University of Lublin and innovation management in the health care sector from Kozminski University. Additionally, she earned an MSc in biology with a focus on microbiology from the University of Warsaw and is a certified laboratory diagnostician. Dr. Guzek leads a multidisciplinary team overseeing comprehensive microbiological diagnostics, implementation of advanced diagnostic methods, and the development of institutional policies on infection control and antibiotic stewardship. Her research contributions include studies on antimicrobial resistance, hospital infection control, and the advancement of microbiological procedures, with numerous publications and citations in recognized scientific sources. She collaborates with national and reference laboratories, contributing to public health and medical innovation. Her exemplary service has been recognized with prestigious honors, including the first place in the Hippocrates Medical Poll for Laboratory Diagnostician of the Year and the Badge of Honour from the Military Medical Institute for her efforts during the COVID-19 pandemic. Dr. Guzek also holds certification in Good Clinical Practice (ICH E6 R2), underscoring her commitment to excellence in research and clinical integrity.

Profiles: Scopus | ORCID

Featured Publications

1. Guzek, A., et al. (2025). Microbiological comparison of maxillary sinus rinses in non-odontogenic and odontogenic sinusitis of primarily endodontic origin. Journal of Clinical Medicine.

2. Guzek, A., et al. (2024). Outcomes of 23 patients diagnosed with New Delhi metallo-beta-lactamase (NDM)-producing Klebsiella pneumoniae infection treated with ceftazidime/avibactam and aztreonam at a single center in Poland. Journal of Clinical Medicine.

3. Guzek, A., et al. (2024). Dissemination of extensively drug-resistant NDM-producing Providencia stuartii in Europe linked to patients transferred from Ukraine, March 2022 to March 2023. Eurosurveillance.

Zaid Khan | Clinical Pharmacist | Young Researcher Award

Published on | Editorial Board by World Top Scientists

Dr. Zaid Khan | Clinical Pharmacist | Young Researcher Award

Zaid Khan | Aditya Bangalore Institute of Pharmacy Education and Research | India

Dr. Zaid Khan is a dedicated and emerging researcher in pharmaceutical sciences with a Doctor of Pharmacy background. He has gained valuable clinical and research experience through internships in reputed hospitals and research institutions, where he contributed to projects involving antibiotic prophylaxis, medication therapy management, and pain management. His work demonstrates strong analytical, clinical, and research design skills, complemented by effective communication and patient counseling abilities. Dr. Khan has published and presented research at national and international platforms and actively engages in professional development through workshops and conferences. His achievements, including recognition as a Young Researcher Award recipient, reflect his commitment to advancing clinical pharmacy and drug safety practices. With a strong interest in bridging research and clinical application, Dr. Khan aspires to contribute to innovative therapeutic strategies, pharmacovigilance, and evidence-based healthcare, positioning himself as a promising professional in the evolving field of pharmaceutical research.

Profiles: Google Scholar | ORCID

Featured Publications

1. Khan, Z., Krishna, D., Daga, S., Rastogih, N., Rekha, M., & Patel, K. (2023). Advancements in minimally invasive surgery: A comprehensive analysis of robotic surgery, endoscopic techniques, and natural orifice translumenal endoscopic surgery. Georgian Medical News, 87–92.

2. Khan, Z., Rekha, M. M., Hiremath, S. R. R., & Shapur, S. R. (2025). A comprehensive study on antibiotic prophylaxis practices across diverse surgical modalities. Journal of Pharmaceutical Care, 93–100.

3. Khan, Z., Ramya, C. V., PR, D. S., & Vishwanath, B. A. (2025). Development and computational analysis of polyherbal chewable lozenges for effective management of mouth and throat infections. Palestinian Medical and Pharmaceutical Journal.

4. Khan, Z. (2024). A case report of advanced periampullary carcinoma: Palliative chemotherapy following Whipple’s surgery. Research & Reviews: Journal of Oncology and Hematology, 13.

5. Zaid, K., & Khan, Z. (2023). Beyond chemotherapy: The promise of immunotherapy in cancer care and advancements in cancer therapy. Research & Reviews: A Journal of Immunology, 13(2), 22–37.

Abdullah Al Nahian | Data Analyst | Best Research Article Award

Published on | Editorial Board by World Top Scientists

Mr. Abdullah Al Nahian | Data Analyst | Best Research Article Award

Healthcare Data Analyst at Children’s Clinic of Michigan, United States

Mr. Abdullah Al Nahian is a dedicated professional and researcher with a strong background in data analytics, computer science, and information systems. His career spans diverse roles including data analyst, network engineer, software developer, and project coordinator, where he has consistently demonstrated expertise in data analysis, system optimization, and project management. Academically, he holds advanced education in information studies and computer science, complemented by certifications in project management, cybersecurity, and database systems. His research contributions focus on impactful areas such as predictive modeling for healthcare outcomes, machine learning applications in cancer stage classification, and neural network-based recognition systems, which have been published in reputable scientific platforms. Abdullah’s work bridges technical innovation with practical applications, particularly in healthcare and information technology, underscoring his ability to contribute solutions to real-world challenges. His combination of academic rigor, technical expertise, and professional experience highlights him as a promising researcher and thought leader in his field.

Professional Profile 

Google Scholar

Education

Mr. Abdullah Al Nahian has built a strong academic foundation that supports his career in technology and research. He earned his Bachelor of Science in Computer Science and Engineering from the University of Liberal Arts Bangladesh, where he developed core knowledge in programming, software development, and system design. To further strengthen his expertise, he pursued a Master of Science in Information Studies at Trine University, Detroit, with a focus on data analytics, information systems, and applied research. His academic journey has been complemented by professional certifications, including Project Management Professional (PMP), Advanced Database, and Cybersecurity, which add specialized knowledge to his technical profile. This combination of formal education and certifications demonstrates his commitment to continuous learning and skill development. By bridging theoretical understanding with practical applications, his educational background provides a strong base for his professional roles and impactful research contributions in data science, healthcare analytics, and machine learning.

Experience

Mr. Abdullah Al Nahian brings extensive professional experience across multiple domains of information technology, data analysis, and project management. Currently working as a Data Analyst at the Children’s Clinic of Michigan, he specializes in gathering, securing, and analyzing healthcare data to improve patient outcomes and operational efficiency. His previous roles include Assistant Coordinator at Polock Group BD, Network Engineer and Assistant Manager at Agni Systems Ltd., and Software Developer at NKSoft BD. Across these roles, he developed expertise in network engineering, customer support, ERP systems, project coordination, and administrative leadership. His career began with web development, gradually expanding to more advanced responsibilities involving data-driven decision-making, system monitoring, and organizational leadership. This progression highlights his adaptability and growth across technical and managerial domains. Additionally, his volunteer work as an IT Specialist further demonstrates his dedication to using technology for organizational improvement and staff empowerment. Collectively, his diverse experience reflects both technical mastery and leadership capability.

Research Focus

Mr. Abdullah Al Nahian’s research focuses on the intersection of data science, healthcare, and machine learning, reflecting both technical innovation and practical significance. His work includes developing predictive models to optimize healthcare outcomes, leveraging data-driven insights to improve patient care and resource management. He has also co-authored research on cancer stage classification using numerical biomarker data, showcasing the role of artificial intelligence in advancing medical diagnosis. Beyond healthcare, his contributions extend to neural network-powered recognition systems, such as automated license plate detection, and in-depth studies on project management and visualization techniques. His approach emphasizes applying computational methods to solve real-world problems, combining theoretical rigor with practical utility. Through his publications in recognized scientific platforms, he demonstrates a commitment to advancing knowledge in applied machine learning, data analytics, and information systems. His research is notable for addressing global challenges in healthcare and technology, bridging academic inquiry with societal impact.

Award and Honor

Mr. Abdullah Al Nahian has established himself as a promising researcher whose academic and professional achievements make him a strong candidate for recognition. His research contributions, published in respected scientific journals and platforms, reflect innovation and applicability in critical domains such as healthcare analytics, artificial intelligence, and project management. Co-authoring multiple peer-reviewed publications within a short period demonstrates his dedication to scholarly excellence and collaborative research. His academic journey, complemented by certifications in project management and cybersecurity, highlights his commitment to professional growth and expertise. In professional settings, he has consistently been recognized for leadership, technical problem-solving, and delivering solutions that improve organizational performance. While his portfolio primarily emphasizes research and professional contributions, his trajectory indicates strong potential for continued recognition through awards that honor innovation, interdisciplinary impact, and societal value. His blend of academic, research, and professional accomplishments positions him as a valuable contributor deserving of future honors.

Publications Top Notes

  • Title: Optimizing Healthcare Outcomes through Data-Driven Predictive Modeling
    Authors: MNM Sunny, MBH Saki, A Al Nahian, SW Ahmed, MN Shorif, J Atayeva, …
    Year: 2024
    Citations: 33

  • Title: Project Management and Visualization Techniques A Details Study
    Authors: MNM Sunny, MBH Sakil, A Al
    Year: 2024
    Citations: 24

  • Title: Neural Network-Powered License Plate Recognition System Design
    Authors: S Hasan, MNM Sunny, A Al Nahian, M Yasin
    Year: 2024
    Citations: 19

  • Title: Classification of Cancer Stages Using Machine Learning on Numerical Biomarker Data
    Authors: MNM Sunny, MM Amin, MH Akter, KMS Hossain, A Al Nahian, J Atayeva
    Year: 2024
    Citations: 3

  • Title: Optimizing Prescription Practices Using AI-Powered Drug Substitution Models to Reduce Unnecessary Healthcare Expenditures in Outpatient Settings
    Authors: A Al Nahian, S Samia, MTM Hussan, F Mahmud, MNM Sunny, SW Ahmed, …
    Year: 2025

  • Title: A Critical Review of Network Management Tools and Technologies in the Digital Age
    Authors: AAN Zakia Sultnana Munmun, Md Minhajul Amin, K M Shihab Hossain
    Year: 2024

Conclusion

Mr. Abdullah Al Nahian’s research portfolio demonstrates a consistent focus on applying data-driven approaches and machine learning techniques to solve critical challenges in healthcare, project management, and technology systems. His publications reflect both academic rigor and practical relevance, particularly in predictive healthcare modeling, cancer diagnosis, and AI-powered optimization solutions. The diversity of his work, ranging from network technologies to medical applications, highlights his ability to bridge interdisciplinary fields and contribute meaningful innovations. With multiple citations already attributed to his recent publications, his research is gaining recognition and impact in the academic community. His role as co-author in several high-quality studies also emphasizes strong collaboration skills and commitment to advancing collective knowledge. Overall, his contributions position him as a capable and promising researcher whose work holds significant value for both academic advancement and real-world problem-solving.

Yoana Dyankova | Medicine and Dentistry | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Dr. Yoana Dyankova | Medicine and Dentistry | Best Researcher Award

Doctor at Medical University, Varna, Bulgaria

Dr. Yoana Dyankova Dyankova is a dedicated pediatrician and clinical researcher specializing in pediatric gastroenterology, hepatology, and nutrition. She holds a PhD in Pediatrics from the Medical University “Prof. Dr. Paraskev Stoyanov” in Varna, Bulgaria, where she also serves in the Pediatric Intensive Care Unit at St. Marina University Hospital. Her research focuses primarily on celiac disease in children, particularly its impact on bone health, as demonstrated in her dissertation and multiple peer-reviewed publications, including a recent article in Nutrients (2025). Dr. Dyankova is an active member of national pediatric and gastroenterology associations and contributes to both clinical care and academic development. Fluent in English and German, she engages with the international scientific community and remains committed to translating research into improved patient outcomes. With her growing publication record, clinical integration, and academic rigor, she stands out as a promising young researcher in the field of pediatric medicine.

Professional Profile 

Google Scholar
ORCID Profile 

Education

Dr. Yoana Dyankova Dyankova began her academic journey at the Vasil Drumev High School of Natural Sciences and Mathematics in Veliko Tarnovo, graduating in 2010. She pursued her medical degree at the Medical University “Prof. Dr. Paraskev Stoyanov” in Varna, Bulgaria, completing it in 2016. From 2017 to 2022, she specialized in pediatrics, gaining comprehensive clinical training and board certification in the field. In 2018, she enrolled in a PhD program in Pediatrics at the same university, where she focused her research on celiac disease and its effects on pediatric bone health. She successfully defended her dissertation in 2023. Dr. Dyankova has since continued to develop professionally by pursuing further specialization in pediatric gastroenterology starting in July 2025. Her academic path demonstrates strong commitment, discipline, and a focused interest in improving pediatric healthcare through both clinical practice and rigorous scientific research.

Professional Experience

Dr. Dyankova has cultivated a balanced career combining clinical excellence and academic growth. Since January 2022, she has served as a pediatrician at the Pediatric Intensive Care Unit (PICU) of the First Children’s Clinic, St. Marina University Hospital in Varna. Her role in the PICU places her at the frontline of managing critically ill children, often requiring advanced decision-making and teamwork in high-pressure situations. Prior to this, she completed a five-year pediatric residency, gaining hands-on experience in general pediatrics. Her transition into the subspecialty of pediatric gastroenterology as of July 2025 marks a strategic shift aligned with her research interests. Parallel to her clinical duties, Dr. Dyankova was engaged in doctoral studies for five years, conducting original research and contributing to academic publications. Her dual role as both a clinician and researcher enhances her ability to apply scientific findings directly to patient care, making her a valuable asset in modern pediatric medicine.

Research Interest

Dr. Dyankova’s primary research interests lie at the intersection of pediatric gastroenterology, hepatology, and nutrition, with a concentrated focus on celiac disease (CD). Her doctoral thesis explored bone health in children with CD, addressing the metabolic and developmental complications arising from malabsorption and chronic inflammation. Beyond celiac disease, she has expressed research interest in related gastrointestinal disorders such as inflammatory bowel disease (IBD), as well as broader issues within pediatric intensive care. Her work is characterized by clinical relevance and translational value, aiming to bridge the gap between scientific research and bedside care. Publications in both national and international journals reflect her dedication to improving diagnostic and treatment protocols in children with chronic gastrointestinal conditions. Dr. Dyankova continues to build her research portfolio by participating in collaborative studies, focusing on early diagnosis, nutritional interventions, and long-term management outcomes in affected pediatric populations, ensuring a direct impact on clinical practice.

Award and Honor

While specific named awards are not listed in the biography, Dr. Yoana Dyankova Dyankova has received notable academic and professional recognition through her successful completion of a PhD and multiple scientific publications. Her research has been published in reputable journals such as Nutrients, indicating peer validation and relevance of her work. She is an active member of the National Pediatric Association and the community of Pediatric Gastroenterologists in Bulgaria, reflecting her standing in the professional community. These memberships signify not only recognition by peers but also her continued contribution to scientific discussions and advancements in pediatric healthcare. Her role in high-stakes clinical environments like the Pediatric Intensive Care Unit further demonstrates trust in her medical competence and decision-making. With growing academic output and clear specialization in a crucial field, Dr. Dyankova is well-positioned to earn future distinctions and leadership roles in pediatric research and clinical practice at both national and international levels.

Conclusion

Dr. Yoana Dyankova Dyankova exemplifies the qualities of a dedicated clinician-scientist, balancing hands-on pediatric care with high-impact academic research. With a solid foundation in pediatrics and a focused interest in gastroenterology and nutrition, she has steadily advanced her career through both clinical excellence and scholarly contribution. Her doctoral work on bone health in children with celiac disease highlights her ability to address complex, real-world health challenges through evidence-based research. Now working in a pediatric intensive care setting and continuing her subspecialty training, Dr. Dyankova is expanding her expertise and influence in critical areas of child health. Her publications, professional affiliations, and academic achievements underscore a deep commitment to the advancement of pediatric medicine. While still early in her career, her trajectory suggests strong potential for leadership in research and healthcare. She is a promising candidate for recognition such as the Best Researcher Award and is well-poised for continued professional impact.

Publications Top Notes

  1. Title: Presentation of Childhood Newly-Diagnosed Diabetes During the COVID-19 Pandemic – Is There a Change?

    • Authors: Y. Bazdarska, V. Iotova, T. Karamfilova, Y. Dyankova, T. Stefanova, …

    • Journal: Diabetes Technology & Therapeutics, Vol. 23, A202

    • Year: 2021

  1. Title: Delayed Bone Age and Osteoprotegerin Levels in Pediatric Celiac Disease: A Three-Year Case–Control Study

    • Authors: R. Pancheva, Y. Dyankova, N. Rasheva, K. Koleva, V. Iotova, M. Dzhogova, M. Fiore, M. Georgieva

    • Journal: Nutrients, Vol. 17 (14), Article 2295

    • Year: 2025

  1. Title: Macrophage Activation Syndrome After COVID-19 Infection in a Patient with Systemic Juvenile Idiopathic Arthritis

    • Authors: M. Boyadzhiev, B. Varbanova, M. Belcheva, P. Shivachev, D. Krumova, Y. Dyankova, …

    • Journal: Scripta Scientifica Medica, Vol. 55(1), pp. 27–31

    • Year: 2023

  1. Title: Bone Health in Children with Celiac Disease (PhD Dissertation)

    • Author: Y. Dyankova

    • Database: PQDT-Global (ProQuest Dissertations)

    • Year: 2022

  1. Title: New Developments in the Diagnostics of Celiac Disease in Children

    • Authors: Y. Dyankova, M. Georgieva, N. Rasheva, K. Koleva

    • Journal: Journal of the Union of Scientists-Varna. Medicine and Ecology Series, Vol. 24(1)

    • Year: 2019

  1. Title: Bacterial Pulmonary Colonization with Pseudomonas aeruginosa in Cystic Fibrosis Patients

    • Authors: M. Nikolova, Y. Dyankova, I. Hristov, M. Georgieva

    • Journal: Izvestia Journal of the Union of Scientists-Varna. Medicine and Ecology Series

    • Year: 2019